Efficacy of Mazdutide for Treating PCOS
The goal of this clinical trial is to learn the efficacy of Mazdutide in treating obese female adults diagnosed with polycystic ovary syndrome (PCOS). The main question it aims to answer is: Does Mazdutide lower the free androgen index (FAI) in obese female adults with PCOS? Participants will take Mazdutide once every week for 24 weeks and visit the clinic once every 4 weeks for checkups and tests.
Polycystic Ovary Syndrome
DRUG: Mazdutide
Free Androgen Index (FAI), FAI=total testosterone (nmol/L)/ sex hormone binding globulin (nmol/L) X 100, 24 weeks
Times of regular menses, Record of vaginal bleeding within 24 weeks after using Mazdutide, 24 weeks|Number of immature follicles, Total number of follicles measuring 2-9 mm in diameter on ultrasound, 24 weeks|Bilateral ovary volume, Total ovary volume is calculated based on length, width and height of bilateral ovaries measured by ultrasound, 24 weeks|Serum anti-Mullerian hormone (AMH), Measurement of serum AMH, 24 weeks|HOMA insulin resistance index (HOMA-IR), HOMA-IR=fasting plasma glucose (mmol/L)×fasting insulin (μU/mlINS)/22.5, 24 weeks|HbA1c, Measurement of HbA1c, 24 weeks|body mass index (BMI), BMI = weight / height² (weight in kilograms and height in meters), 24 weeks
The goal of this clinical trial is to learn the efficacy of Mazdutide in treating obese female adults diagnosed with polycystic ovary syndrome (PCOS). The main question it aims to answer is: Does Mazdutide lower the free androgen index (FAI) in obese female adults with PCOS? Participants will take Mazdutide once every week for 24 weeks and visit the clinic once every 4 weeks for checkups and tests.